EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis

Eye absent homolog 4 (EYA4) has been demonstrated to be down‐regulated in hepatocellular carcinoma (HCC), but its biological function and the mechanism in HCC angiogenesis and metastasis remain largely unknown. Herein, we showed that EYA4 expression was frequently low in HCC tissue samples compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Fangming, Yuan, Shengxian, Liu, Lei, Zhu, Peng, Yang, Yuan, Pan, Zeya, Zhou, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533515/
https://www.ncbi.nlm.nih.gov/pubmed/30957411
http://dx.doi.org/10.1111/jcmm.14309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533515/
https://www.ncbi.nlm.nih.gov/pubmed/30957411
http://dx.doi.org/10.1111/jcmm.14309

Ejemplares similares